HIGHLIGHTS
- who: Matthew K Burrage from the Oxford Centre for Clinical Cardiovascular Magnetic Resonance Research (OCMR) have published the research work: Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility, in the Journal: (JOURNAL)
- what: The surprising (yet positive) results of studies such as EMPA-REG which showed a significant benefit to cardiovascular mortality in T2DM patients with improved glycaemic control provided by empagliflozin, a sodium-glucose co-transporter 2 inhibitor , potentially by procuring a shift in cardiac metabolism , has led to a recent clinical trial aiming to replicate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.